"The U.S. Food and Drug Administration today approved Alprolix, Coagulation Factor IX (Recombinant), Fc Fusion Protein, for use in adults and children who have Hemophilia B. Alprolix is the first Hemophilia B treatment designed to require less fre"...
RiaSTAP Patient Information including If I Miss a Dose
In this Article
- What is fibrinogen (RiaSTAP)?
- What are the possible side effects of fibrinogen (RiaSTAP)?
- What is the most important information I should know about fibrinogen (RiaSTAP)?
- What should I discuss with my health care provider before using fibrinogen (RiaSTAP)?
- How should I use fibrinogen (RiaSTAP)?
- What happens if I miss a dose (RiaSTAP)?
- What happens if I overdose (RiaSTAP)?
- What should I avoid while taking fibrinogen (RiaSTAP)?
- What other drugs will affect fibrinogen (RiaSTAP)?
- Where can I get more information?
What happens if I miss a dose (RiaSTAP)?
Use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.
What happens if I overdose (RiaSTAP)?
Seek emergency medical attention if you think you have used too much of this medicine.
Symptoms of a fibrinogen overdose are not known.
What should I avoid while taking fibrinogen (RiaSTAP)?
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using fibrinogen.
What other drugs will affect fibrinogen (RiaSTAP)?
There may be other drugs that can interact with fibrinogen. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
Where can I get more information?
Your pharmacist can provide more information about fibrinogen.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 1.04. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional RiaSTAP Information
Report Problems to the Food and Drug Administration
Find out what women really need.